Showing results (251-260 of 1,593) with videos related to
Sort By:
Pageof 160
The Journal of Pharmacology and Experimental Therapeutics|July 10, 1998
Prediction of in vivo nonlinear first-pass hepatic metabolism of YM796 from in vitro metabolic dataT Iwatsubo, A Hisaka, H Suzuki, et al.Jikken Dobutsu. Experimental Animals|July 1, 1991
Pathogenesis of a newly isolated rat virus in newborn and juvenile ratsK Yagami, T Fukazawa, Y Sugiyama, et al.The Journal of Pharmacology and Experimental Therapeutics|December 23, 1998
Renal drug targeting using a vector "alkylglycoside"K Suzuki, H Susaki, S Okuno, et al.Biopharmaceutics & Drug Disposition|December 1, 1996
Tissue-selective uptake of pravastatin in rats: contribution of a specific carrier-mediated uptake systemM Yamazaki, T Tokui, M Ishigami, et al.Journal of Neurosurgery|December 1, 1976
Brain abscess caused by Salmonella typhi. Case reportY Suzuki, Y Sugiyama, R Ishii, et al.The Journal of Pharmacology and Experimental Therapeutics|February 1, 1997
Carrier-mediated active transport of the glucuronide and sulfate of 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole (E3040) into rat liver: quantitative comparison of permeability in isolated hepatocytes, perfused liver and liver in vivoO Takenaka, T Horie, H Suzuki, et al.Pharmaceutical Research|October 1, 1996
Uptake is the rate-limiting step in the overall hepatic elimination of pravastatin at steady-state in ratsM Yamazaki, S Akiyama, R Nishigaki, et al.Nihon Rinsho. Japanese Journal of Clinical Medicine|March 1, 1996
[Preparation of plasma membrane and the analysis of transport kinetics and driving forces]K Niinuma, H Suzuki, M Yamazaki, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 21, 2000
Both cMOAT/MRP2 and another unknown transporter(s) are responsible for the biliary excretion of glucuronide conjugate of the nonpeptide angiotensin II antagonist, telmisaltanA Nishino, Y Kato, T Igarashi, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 20, 1999
[Recent progress in biological therapies for cancer]S Saji, Y Sugiyama, K Kunieda, et al.Pageof 160